BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34627626)

  • 1. Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond.
    Mukherjee N; Julián E; Torrelles JB; Svatek RS
    Vaccine; 2021 Dec; 39(50):7332-7340. PubMed ID: 34627626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette-Guérin treatment against bladder cancer.
    Takeuchi A; Dejima T; Yamada H; Shibata K; Nakamura R; Eto M; Nakatani T; Naito S; Yoshikai Y
    Eur J Immunol; 2011 Jan; 41(1):246-51. PubMed ID: 21182095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
    Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
    Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection.
    Pi J; Zhang Z; Yang E; Chen L; Zeng L; Chen Y; Wang R; Huang D; Fan S; Lin W; Shen H; Xu JF; Zeng G; Shen L
    J Nanobiotechnology; 2022 Jan; 20(1):36. PubMed ID: 35033108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
    Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
    Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.
    Setiabudiawan TP; Reurink RK; Hill PC; Netea MG; van Crevel R; Koeken VACM
    Med; 2022 Jan; 3(1):6-24. PubMed ID: 35590145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteomyelitis and septic arthritis after Mycobacterium Bovis BCG Therapy for Urinary Bladder Cancer.
    Lee SC; Geannette CS
    Clin Imaging; 2020 Dec; 68():179-183. PubMed ID: 32841934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants.
    Zufferey C; Germano S; Dutta B; Ritz N; Curtis N
    PLoS One; 2013; 8(10):e77334. PubMed ID: 24098583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer.
    Takeuchi A; Eto M; Tatsugami K; Shiota M; Yamada H; Kamiryo Y; Dejima T; Kashiwagi E; Kiyoshima K; Inokuchi J; Takahashi R; Yokomizo A; Ohara N; Yoshikai Y
    Int Immunopharmacol; 2016 Jun; 35():327-331. PubMed ID: 27093372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.
    Park CH; Jang MA; Ahn YH; Hwang YY; Ki CS; Lee NY
    Korean J Lab Med; 2011 Jul; 31(3):197-200. PubMed ID: 21779195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine.
    Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S
    Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.
    Venkataswamy MM; Baena A; Goldberg MF; Bricard G; Im JS; Chan J; Reddington F; Besra GS; Jacobs WR; Porcelli SA
    J Immunol; 2009 Aug; 183(3):1644-56. PubMed ID: 19620317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded
    Esteso G; Felgueres MJ; García-Jiménez ÁF; Reyburn-Valés C; Benguría A; Vázquez E; Reyburn HT; Aguiló N; Martín C; Puentes E; Murillo I; Rodríguez E; Valés-Gómez M
    Oncoimmunology; 2023; 12(1):2160094. PubMed ID: 36567803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A
    Pittet LF; Fritschi N; Tebruegge M; Dutta B; Donath S; Messina NL; Casalaz D; Hanekom WA; Britton WJ; Robins-Browne R; Curtis N; Ritz N
    Am J Respir Crit Care Med; 2022 Apr; 205(7):830-841. PubMed ID: 35007188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.